ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

ACS Seeks Applications For Clinical Awards

January 1, 1993

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

ONF Offer Grants

February 9, 1996